share_log

和鉑醫藥-B:自願公告 - B7H4X4-1BB雙特異性抗體(HBM7008) I期臨床試驗完成首例患者的首次給藥

HBM HOLDINGS-B: VOLUNTARY ANNOUNCEMENT - COMPLETION OF FIRST DOSING OF FIRST PATIENT OF B7H4X4-1BB BISPECIFIC ANTIBODY (HBM7008) PHASE I TRIALS

May 25, 2022 04:34
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more